首页> 外国专利> Improvements in or relating to androstenone and androstanone derivatives

Improvements in or relating to androstenone and androstanone derivatives

机译:雄烯酮和雄烷酮衍生物的改进或与之有关的改进

摘要

The invention comprises 19-nor-steroids of the general formulae FORM:0885782/IV (b)/1 wherein R is an alkyl, alkenyl or alkynyl radical of less than 5 carbon atoms and R1 is an alkyl radical of less than 5 carbon atoms), but excludes 5a : 17b -dihydroxy-17a -(propynyl) and butynyl)-6b -alkyl-19-nor-androstan-3-ones. The D 4-3-ketones may be prepared from the corresponding 3-ethylenedioxy-5a -hydroxy compounds either directly by the action of a strong concentrated inorganic acid such as hydrochloric acid or by milder hydrolysis with a dilute inorganic, e.g. mineral, acid or a strong organic acid to give the 5a -hydroxy-3-ketones and then dehydration of these with a dilute base such as sodium hydroxide. In examples (1) and (2) 3-ethylenedioxy-17a -ethyl-19-nor-5-androsten -17-ol is prepared in the usual way from the D 4-3-ketone and then converted to the 5X : 6X-epoxide, this is reacted with a methyl Grignard reagent to give the corresponding 6b -methyl-5a -ol, this with acetic acid gives the 6b -methyl-5a -hydroxy-3-ketone and this is dehydrated and epimerized with dilute alcoholic KOH to 17b -hydroxy - 17a - ethyl - 6a - methyl - 19 - nor 4 - androsten-3-one; (3) the corresponding 17a -propyl compounds are similarly prepared; (4) -(6) b -methoxy-19-nor-2 : 5(10)-androstadien -17b -ol with ethylene glycol gives 3-ethylenedioxy -19-nor-5-androsten-17b -ol (also obtainable from the D 4-3-ketone), this is converted to the 17 -acetate, this to the 5a : 6 a -epoxide, this to the 6b -methyl-5a -ol and this by an Oppenauer oxidation to 3-ethylenedioxy-5a -hydroxy-6b -methyl - 19 - nor - androstan - 17 - one, this with 2-methallyl magnesium chloride gives 3-ethylene -dioxy - 17a - (2 - methallyl) - 6b - methyl - 19 - norandrostan -5a : 17b -diol or with the corresponding allyl Grignard reagent the 17a -allyl compound and these are converted as in examples (1) and (2) to the 6b -methyl-5a -hydroxy-3-ketones and the 6a -methyl-D 4-3-ketones, the 2-methallyl compound also being converted by catalytic hydrogenation to 17b -hydroxy-17a -isobutyl - 6a - methyl - 19 - nor - 4 - androstan - 3 -one; (7) 3-ethylenedioxy-5a -hydroxy-6b -methyl -19-norandrostan-17-one is reacted with acetylene to give 3-ethylenedioxy-17a -ethynyl-6b -methyl-19 -norandrostane-5a : 17b -diol and this is converted as in (1) and (2) to the corresponding 3-ketone and then the 6a -methyl-D 4-3-ketone; (8) the ethylenedioxy intermediate of (7) is reacted with methyliodide in presence of ethyl magnesium bromide to give 3-ethylenedioxy-17a -(1-propynyl) -6b - methyl - 19 - norandrostane - 5a : 17b - diol and this is converted directly by the action of hydrochloric acid to 6a -methyl-17b -hydroxy-17a -(1 - propynyl) - 19 - nor - 4 - androstan - 3 - one; and (9) 6a -methyl-17b -hydroxy-17a -(1-butynyl) -19-nor-4-androsten-3-one is similarly prepared.
机译:本发明包含通式的19-去-甾族化合物,其中R是少于5个碳原子的烷基,烯基或炔基,R 1是少于5的烷基。碳原子),但不包括5a:17b-二羟基-17a-(丙炔基)和丁炔基)-6b-烷基-19-去甲雄烷-3-酮。 D 4-3-酮可由相应的3-乙烯二氧基-5a-羟基化合物直接通过强浓无机酸(例如盐酸)的作用或通过与稀无机物(例如碳酸氢钠)的温和水解而制备。无机酸,强酸或强有机酸,得到5a-羟基-3-酮,然后用稀碱(如氢氧化钠)脱水。在实施例(1)和(2)中,以通常的方式由D 4-3-酮制备3-乙撑二氧基-17a-乙基-19-去甲-5-去氧雄蕊-17-ol,然后转化为5X:6X -环氧化物,与甲基格氏试剂反应生成相应的6b-甲基-5a-醇,与乙酸生成6b-甲基-5a-羟基-3-酮,将其脱水并与稀醇KOH异构化至17b-羟基-17a-乙基-6a-甲基-19-也不4-雄烯-3- (3)类似地制备相应的17a-丙基化合物; (4)-(6)b-甲氧基-19-nor-2:5(10)-androstadien -17b -ol与乙二醇反应生成3-乙二氧基-19-nor-5-androsten-17b -ol(也可从以下获得D 4-3-酮),将其转化为17-乙酸酯,将其转化为5a:6a-环氧化物,将其转化为6b-甲基-5a-ol,并通过Oppenauer氧化为3-乙烯二氧基-5a -羟基-6b-甲基-19-去甲雄烷-17-一个,与2-甲基烯丙基氯化镁制得3-乙烯-二氧基-17a-(2-甲代烯丙基)-6b-甲基-19-诺兰斯坦-5a:17b -二醇或与相应的烯丙基格氏试剂一起的17a-烯丙基化合物,如实施例(1)和(2)所述,将其转化为6b-甲基-5a-羟基-3-酮和6a-甲基-D 4- 3-酮,该2-甲基烯丙基化合物也通过催化氢化转化为17b-羟基-17a-异丁基-6a-甲基-19-去甲-4-雄烷-3-酮; (7)使3-乙撑二氧基-5a-羟基-6b-甲基-19-去氧雄甾烷-17-与乙炔反应,得到3-乙撑二氧-17a-乙炔基-6b-甲基-19-去雄甾烷-5a:17b-二醇和将其如(1)和(2)中那样转化为相应的3-酮,然后转化为6a-甲基-D 4-3-酮; (8)使(7)的乙二氧基中间体在乙基溴化镁存在下与碘甲烷反应,得到3-乙二氧基-17a-(1-丙炔基)-6b-甲基-19-壬烷锡-5a:17b-二醇,在盐酸的作用下直接转化为6a-甲基-17b-羟基-17a-(1-丙炔基)-19-也不-4-雄烷-3- (9)类似地制备6a-甲基-17b-羟基-17a-(1-丁炔基)-19-去甲-4-雄烷-3-。

著录项

  • 公开/公告号GB885782A

    专利类型

  • 公开/公告日1961-12-28

    原文格式PDF

  • 申请/专利权人 G. D. SEARLE & CO.;

    申请/专利号GB19590002434

  • 发明设计人

    申请日1959-01-22

  • 分类号C07J1/00;C07J75/00;

  • 国家 GB

  • 入库时间 2022-08-23 17:40:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号